Bristol-Myers Squibb Company
COMPOSITIONS AND METHODS OF TREATING CANCER
Last updated:
Abstract:
The disclosure is directed to methods of treating cancer in subjects with a combination of a monoclonal antibody and (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propana- mide, or a salt thereof.
Status:
Application
Type:
Utility
Filling date:
28 Sep 2018
Issue date:
4 Feb 2021